An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Clinical trial NCT02917993 · COMPLETED
Trial details
- NCT number
- NCT02917993
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2025-12-24
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.